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Abstract 
This paper examines the two-way relationship between managerial compensation and 
corporate risk by exploiting an unanticipated change in firms’ business risks. The natural 
experiment provides an opportunity to examine two classic questions related to incentives 
and risk—how boards adjust incentives in response to firms’ risk and how these 
incentives affect managers’ risk-taking. We find that, after left-tail risk increases, boards 
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“CEO Compensation and Corporate Risk:  
Evidence from a Natural Experiment” 
 
 Convex managerial payoffs and firm risk are known to be correlated, but the direction of 
causality remains unclear. 
 We exploit a change in risk to show how boards adjust incentives and how these incentives affect 
managers’ risk-taking.  
 We find that firms reduce managers’ exposure to stock price movements after left-tail risk 
increases. 
 Because the change in risk is unanticipated, we can also identify compensation’s effect on risk-
taking in the new environment. 
 Our results show that convexity from options can encourage risk-taking in corporate 
investment and financing decisions.  
 
 1. Introduction 
Option-based compensation for corporate executives has grown significantly over the past 30 
years. It is commonly believed that stock options provide managers with incentives to take risks, but the 
evidence remains unclear. Even less is known about how boards of directors design and adjust managers’ 
incentives in light of firms’ risk environments. The lack of definitive findings may seem surprising given 
that the issue has been studied extensively. However, theoretical predictions are varied and overcoming 
identification concerns remains challenging. In this paper, we take a new approach to these classic issues 
in an attempt to augment our understanding of the relationship between risk and incentives. 
Providing empirical evidence is important because theory’s prediction of how options affect risk-
taking incentives is ambiguous. On the one hand, options’ convex payoffs create an incentive to take risk 
because managers share in the gains but not all of the losses. This intuition appears in Jensen and 
Meckling (1976), Myers (1977), Smith and Stulz (1985), and Smith and Watts (1992).1  On the other 
hand, Lambert et al. (1991) show that, because options contain a leveraged position in the firm’s equity, 
options also have the potential to magnify a risk-averse manager’s exposure to the firm’s risk and thus 
reduce the manager’s appetite for risk taking.2   
Despite this theoretical ambiguity, there is a wealth of empirical evidence highlighting a positive 
correlation between the use of options in pay and various measures of risk, such as stock-return volatility. 
Work of this nature dates back to Agrawal and Mandelker (1987), if not earlier, and extends to Tchistyi et 
al. (2011).3  For example, Guay (1999) shows that it is specifically the convexity of stock options that 
determines the sensitivity of CEO wealth to equity risk. He finds that firms’ stock-return volatility is 
positively associated with the convexity of the CEO’s full compensation package (including previously 
granted stock and options), which has come to be known as “vega”.  
                                                            
1 See also Haugen and Senbet (1981), Bizjak et al. (1993), Gaver and Gaver (1993), and Guay (1999). 
2 Option compensation may also increase or decrease the firm’s risk as a by-product of increasing managerial effort 
(Kadan and Swinkels, 2008). See also Carpenter (2000) and Ross (2004). 
3  Papers documenting a positive association between options and firm risk include DeFusco et al. (1990), Saunders 
et al. (1990), Mehran (1992, 1995), May (1995), Tufano (1996), Berger et al. (1997), Denis et al. (1997), Esty 
(1997a, 1997b), Jolls (1998), Schrand and Unal (1998), Aggarwal and Samwick (1999), Guay (1999), and Knopf et 
al. (2002).  
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 Although this evidence suggests that risk-taking and vega are linked, identifying the causal effect 
of option-based incentives on corporate risk-taking is difficult given the obvious endogeneity of the 
relationship between options and risk. Because managers’ compensation is arguably designed in 
anticipation of a particular risk environment, the possibility of reverse causality is hard to exclude. 
Similar concerns about endogeneity plague the empirical literature on ownership concentration and firm 
value (Demsetz and Lehn, 1985; Himmelberg et al., 1999; Palia, 2001). 
There have been several attempts to solve this identification challenge. A number of papers 
approach this question by estimating a system of simultaneous equations (see Coles et al., 2006; Rajgopal 
and Shevlin, 2002; Rogers 2002). Although this approach makes progress by modeling the effects of vega 
on decisions and vice versa, a fundamental concern remains in that the estimations in these papers require 
arbitrary exclusion restrictions.4 A similar concern applies to Armstrong and Vashishtha (2012) and Shue 
and Townsend (2013), who attempt to resolve the endogeneity problem using instrumental variables.5 
Other recent work attempts to overcome the challenge by analyzing firms’ risk-taking following new 
accounting rules that reduced options pay (Chava and Purnanandam, 2010; Hayes et al., 2012). These 
new accounting rules, however, were known and debated for years in advance, undermining their 
effectiveness as a natural experiment;6 further, because the rule change affected all firms at the same time, 
these analyses lack a compelling counterfactual. In sum, although the estimation strategies in this 
literature have grown more sophisticated and certainly made progress, important identification concerns 
remain. 
We take a step forward in addressing the identification challenge by exploiting changes in firms’ 
business environments that increase left-tail risk (also known as material risk) that can truly be classified 
                                                            
4 Coles et al. (2006) assume that the riskiness of the firm’s business environment does not affect project choice; 
Rajgopal and Shevlin (2002) assume that cash balances and firm size are unrelated to firms’ risk choices; and 
Rogers (2002) assumes that cash balances and stock variance are unrelated to firms’ hedging motives. 
5 Armstrong and Vashishtha (2012) assume that cash balances, marginal tax rates, past stock returns, and past 
profitability are unrelated to the proportion of firms’ overall risk that is systematic. Shue and Townsend (2013) 
exploit the multi-year nature of firms’ fixed value and fixed number option grants to create instruments for when 
managers’ holdings of options increase. This approach requires the assumption that boards set the type and/or 
duration of these plans exogenously and without consideration for the consequences of these choices.   
6 For example, Aboody et al. (2004) highlight that over one hundred firms voluntarily expensed stock options as 
early as 2002 in anticipation of the 2005 adoption of FAS 123R, which was studied by Chava and Purnanandam 
(2010) and Hayes et al. (2012). 
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 as exogenous and unanticipated. Left-tail risks are prevalent in practice and can take the form of 
technological irrelevance, adverse regulatory changes, asset expropriation, and so on. The specific tail 
risk we study is the risk of large legal liabilities and costly regulation. This setting provides an opening to 
examine how managers respond to an increase in business risk as a function of their pre-existing equity-
based incentives. The unanticipated change in risk allows us to exclude the possibility of reverse causality 
between these pre-determined incentives and managers’ subsequent risk-related choices.  
Our empirical analysis centers on a jump in tail risk that is created when a chemical to which a 
firm’s workers have already been exposed is newly identified as a carcinogen. Discovery of a chemical’s 
carcinogenicity increases the likelihood that a firm will need to spend large sums on legal fees, damage 
payments, and insurance premiums in the future. By increasing the probability that cash flows will be 
diverted to cover liability costs, this liability risk directly reduces the expected proceeds from new 
investments that use the chemical as an input to production. The discovery can also create a debt 
overhang problem, as described in Myers (1977). To the extent that future lawsuits or adverse regulatory 
changes might consume the cash returned from a new investment, even if it does not use the carcinogen 
directly, shareholders will be less willing to contribute the capital needed to fund the investment. Even if 
no additional capital needs to be raised, shareholders might prefer for the firm to pay out existing cash 
holdings, by increasing dividends or share repurchases, rather than to fund the new investment.  
Gormley and Matsa (2011) confirm that such workplace exposures to carcinogens can increase a 
firm’s downside risk and reduce shareholders’ willingness to fund new investments. Using data on 
workplace exposures to known carcinogens, historical damage awards, and historical cash flows, 
Gormley and Matsa find that a typical potential legal liability faced by firms appears to be around 5% of 
assets and that such a shock would increase the median probability of distress among exposed firms by 
30-fold. This underestimates the risk, as it does not account for the possibility of adverse future regulatory 
changes.7 Consistent with a decline in shareholders’ desired investment, Gormley and Matsa find that 
shareholders prefer for managers to pay out more cash after the tail risk increases.     
                                                            
7 An analysis of firms’ stock volatility in our sample (discussed later) also suggests that these exposures are salient; 
the variance of stock returns for firms with an exposure increases by 60% after risk increases.   
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 Given the drop in desired investment, boards have reason to reduce managers’ exposure to their 
firms’ risk. With fewer risky projects that shareholders are willing to fund, the boards no longer need to 
provide risk-averse managers with as much pay convexity (vega) or sensitivity to firm value (known as 
“delta”) as incentives to undertake risky investments (e.g., Hirshleifer and Suh, 1992; Smith and Watts, 
1992). Other factors, discussed in Section 2.1, might also cause boards to decrease stock-based incentives 
and lead managers to alter their financial exposure to the firm (e.g., by exercising options). While new 
compensation awards can adjust quickly, managers’ overall sensitivities to stock price movements and 
stock volatility are likely slower to adjust. Vesting schedules restrict the managers’ ability to reduce their 
personal holdings, and it can be costly for firms to modify securities that have already been awarded.  
Consistent with the tail risk reducing shareholders’ desire to fund new investments, we find that 
boards respond by immediately adjusting compensation flows so as to reduce managers’ exposure to their 
firms’ risks. Boards reduce the sensitivities of CEOs’ pay to changes in firm value (delta) and to changes 
in the firm’s risk (vega) in the years immediately after the firm is exposed. In this way, the firms appear to 
actively manage grants of new equity incentives, consistent with Core and Guay (1999). We also find that 
managers seek to reduce their future exposure by exercising a greater number of stock options just after 
the carcinogen is discovered. These results underscore concerns about reverse causality in prior studies of 
CEO incentives’ effect on corporate risk-taking.  
In contrast to our findings for compensation flows, however, we find that the sensitivity of the 
manager’s overall compensation portfolio to firm risk is harder to modify quickly. We find that it takes 
three to five years before the vega and delta of the entire compensation portfolio are significantly reduced. 
That is, although boards react quickly to adjust new incentives in light of the increased risk, these changes 
take time to shift the sensitivity of incumbent CEOs’ total firm-related wealth to firm risk. The opposite is 
true for new CEOs, for whom the board gets a fresh start in fashioning incentives. Indeed, we find that 
new CEOs have significantly lower portfolio vegas than do the CEOs they replace at the exposed firms 
and lower portfolio vegas than do other newly appointed CEOs at unexposed firms. 
To identify an effect of convexity on risk-taking behavior, we make use of a previously 
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 unexplored effect of convexity on risk-taking incentives. Using a theoretical example in the framework of 
Lambert et al. (1991), we show that the convexity of CEOs’ payoffs affects both the desired level of risk-
taking and how sensitive CEOs are to deviations from this level.  Unlike the prior literature, we focus on 
the latter effect of convexity. After an unanticipated increase in risk pushes a risk-averse manager above 
his or her desired level of risk taking, the manager can benefit by reducing risk. However, when the 
manager has a convex payoff, he or she gains less by reducing risk because the reduction lowers the 
expected value of the convex payoff. Higher vega thereby provides the manager with the incentive to 
reduce risk less aggressively.   
The unanticipated increase in left-tail risk thus affords us a unique opportunity to identify a causal 
effect of these incentives on managerial risk-taking. As illustrated by our theoretical framework, the level 
of convexity immediately after risk increases affects risk-taking incentives in the new environment. 
Because the manager’s compensation portfolio structure before the jump in tail risk is highly correlated 
with his or her portfolio immediately afterwards, we can use this predetermined payoff structure to 
analyze how option-based convexity affects managerial responses to an increase in risk, thereby avoiding 
concerns about reverse causality.   
Focusing on a short window of three years after risk increases and excluding any firm-years after 
CEO turnover (because the pre-existing portfolio corresponds to a different CEO and is thus less 
informative in those cases), we find that the convexity of a managers’ pre-existing, equity-based 
incentives is positively related to the increase in their firms’ risk after a carcinogen is discovered. On 
average, exposed firms’ stock variance increases by about 0.10 after the jump in tail risk, and exposed 
firms whose CEOs face high vega see the largest increase in stock variance—a one standard deviation 
greater vega is associated with a 50% larger increase in the stock variance. This finding suggests that 
managers with more convex payoffs are less likely to take actions to offset the increase in left-tail risk and 
provides the most definitive evidence to date that the convexity of managerial pay packages directly 
affects managerial choices with respect to corporate risk. 
We also explore the specific financing and investment choices managers make that affect firm 
risk and find that these choices are also related to managers’ portfolios. Gormley and Matsa (2011) find 
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 that the average firm responds to a jump in tail risk by reducing leverage and diversifying through 
acquisitions of cash-rich firms. We explore heterogeneity in these responses. We find that CEOs with 
high portfolio vegas reduce leverage less than CEOs in other exposed firms. Similarly, we observe 
significantly less stockpiling of cash by CEOs with higher vegas. Convex payoffs also appear to make 
CEOs less likely to engage in diversifying acquisitions and less aggressive in cutting back on risky 
investments, as captured by smaller cuts in their firms’ R&D expenses.    
Our findings do not appear to be driven by omitted variables, which could be a problem if factors 
that are correlated with the initial choice of compensation structure also affect how a firm responds to the 
increase in tail risk for reasons unrelated to compensation. For example, highly risk-averse managers 
might respond more aggressively to reduce risk after tail risk increases. If firms compensate highly risk-
averse managers with less option-based pay, then this might explain the observed correlation between 
convexity and changes in financial and investment decisions. However, theory suggests more risk-averse 
CEOs might actually be given payoffs that are more convex to mitigate the moral hazard problem arising 
from their risk-aversion (e.g., Guay, 1999).8  Our results for vega are also robust to controlling for 
manager fixed effects and interactions of exposure with various measures that are likely to be correlated 
with managerial risk tolerance, including corporate financial vulnerability, external governance, and CEO 
age and tenure. 
Taken together, these results suggest that the structure of managerial compensation has important 
effects on corporate responses to tail risk and that the convex payoffs provided by options do affect risk-
taking incentives. In particular, options can increase a firm’s overall risk by reducing managers’ 
incentives to undertake risk-reducing activities when facing a jump in left-tail risk. Relative to stock, risk-
taking incentives from options’ convexity appear to reduce the sensitivity of a manager’s expected utility 
to deviations from the manager’s desired level of risk.  
Our paper addresses two distinct, but connected, questions regarding managerial compensation 
and risk: how do firms’ risky investment opportunities affect boards’ choices regarding stock-based pay 
                                                            
8 On the other hand, firms might need to offer more risk-averse CEOs less convex payoffs to attract them in the first 
place. 
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 and how do convex payoffs affect managers’ risk-taking incentives? The interconnectedness of these 
questions makes it challenging to answer either question. Identifying how boards adjust pay is difficult 
given the lack of exogenous changes in firms’ risky investment opportunities. As a result, prior research 
typically relies on market-to-book ratios as a measure of growth opportunities (e.g., Smith and Watts, 
1992; Core and Gauy, 1999) or on regulatory changes that affect managers’ incentives to invest in risky 
projects (Cohen, Dey, and Lys, in press). Likewise, identifying how convex payoffs affect managers’ 
risk-taking incentives is complicated by the lack of exogenous changes in such payoffs. Our paper takes a 
new approach to these two questions by analyzing an exogenous increase in tail risk that directly affects 
shareholders’ investment opportunities. 
The remainder of the paper is organized as follows. Section 2 discusses how managers’ portfolios 
respond to tail risk and illustrates how shocks to tail risk can be used to identify options’ effect on 
managerial risk-taking. Section 3 discusses our empirical setting, data sources, and identification strategy. 
Section 4 analyzes how boards adjust equity-based incentives in response to an unanticipated change in 
tail risk. Section 5 examines the managers’ responses to increased risk as a function of their existing 
compensation contract. Section 6 concludes with a discussion of the broader implications of our work. 
2. Theoretical framework  
This paper develops a novel way to use unanticipated shocks to business risk to examine how the 
structure of managers’ compensation portfolios both responds to changes in firms’ background risk and 
affects managerial risk-taking. In this section, we first discuss why managers’ portfolios might respond to 
changes in risk and why these responses pose an identification challenge to many estimates in the existing 
literature. We then show how unanticipated increases in risk can be used to identify both this response 
and compensation’s effect on risk taking.  
 
2.1. Endogeneity of managers’ compensation portfolios to background risk 
The riskiness of firms’ investment opportunities is widely thought to be an important determinant 
of managers’ compensation. Firms often face investment opportunities that have positive net present 
value but feature significant idiosyncratic risk. Because risk-averse managers may be reluctant to take 
7
 such risky projects, boards can use convex payoffs to induce managers to do so (e.g., Hirshleifer and Suh 
1992; Dittmann and Yu 2011; Edmans and Gabaix 2011). This motive for providing convexity is 
strongest for firms with many risky investment opportunities, including growth options (Guay 1999), and 
thus might lead to a positive association between convexity and firm risk.  
In our empirical analysis, we examine how managers’ portfolios respond to the increase of a 
particular type of risk, left-tail risk. Unlike a mean-preserving increase in risk, which maintains the net 
present value of existing projects, an increase in left-tail risk decreases the expected cash flows (and 
NPV) by boosting the probability of a very negative outcome. The left-tail risk reduces the chance that 
shareholders will receive proceeds from the firm’s future investments and affects the manager personally 
through any undiversified wealth that is tied to the value of the firm. As such, a left-tail risk will likely 
lead both boards and managers to adjust the portfolio vega and the portfolio delta.  
Boards have multiple reasons to decrease managers’ portfolio vega and portfolio delta after left-
tail risk increases. By reducing shareholders’ expected cash flows from new investments, the left-tail risk 
reduces shareholders’ willingness to pursue marginal projects, thereby reducing the need to provide a 
risk-averse manager with an incentive to undertake as many risky investments.9 In this scenario, boards 
have reason to reduce managers’ compensation vega. The decrease in desired investments also reduces 
the need for delta (Smith and Watts 1992), as do other factors. Risk-averse executives may require a 
greater premium for holding stock-based pay, which could also lead firms to shift compensation to other 
forms. Finally, reducing managers’ exposure to firm risk, by reducing their stock-based pay, can also 
mitigate agency conflicts arising from managers’ risk aversion (Jensen and Meckling 1976; Amihud and 
Lev 1981; Holmström 1999), which are particularly acute in the presence of left-tail risk (Gormley and 
Matsa 2011).  
Managers also have a personal incentive to limit their financial exposure to their firms’ risk. Left-
tail events, such as bankruptcy and employment loss, can lead to severe personal losses, including the loss 
of private benefits, reputation, and wealth tied to the firm. The most direct way managers can limit their 
exposure to these risks is to alter their financial portfolio (e.g., by exercising options or selling 
                                                            
9 Indeed, Gormley and Matsa (2011) find evidence that shareholders prefer managers to pay out the excess cash 
through dividends and stock repurchases following the increase in tail risk described in Section 3.  
8
 unrestricted stock). To the extent that CEOs influence their own pay, they might also shift their 
compensation away from stock and options. These changes may lower both vega and delta. Furthermore, 
managers can modify the firms’ risk directly by altering corporate investment (Gormley and Matsa, 
2011).  
These effects of risk highlight the endogenous nature of the managers’ compensation contracts.  
Because firms’ risk environment affects the structure of managers’ contracts and because option-based 
pay may in turn affect risk-taking incentives, it is difficult to identify either causal effect by simply 
comparing measures of risk-taking to managers’ portfolio vega and delta. As we describe next, 
unanticipated shocks to tail risk can be used to overcome these identification challenges.    
 
2.2. Identification based on shocks to business risk  
It is straightforward to see how an exogenous increase in business risk can be used to identify 
how firms’ risk affects the structure of managers’ compensation portfolios. Under plausible assumptions, 
the shock to business risk also allows us to identify how the structure of managers’ compensation 
portfolios, including their convexity, affects managers’ risk-taking. 
To illustrate how we identify the effect of convex payoffs on risk-taking, we derive the expected 
utility and marginal expected utility with respect to risk for a manager with different portfolios. Following 
Lambert et al. (1991), we model a portfolio as a combination of cash, stock, and options that provides a 
risky payoff, Z(P), at the end of the period, and this payoff is a function of the firm’s stock price, P. This 
portfolio can be thought of as the combination of both past and current compensation paid to the manager 
by the firm’s shareholders, along with the manager’s outside wealth (including cash, real estate, or other 
investments), which is not tied to the firm’s performance. The stock price P is assumed to be a random 
variable with cumulative probability distribution F(P) and density function f(P), and is bounded below by 
zero. Letting U(x) represent the manager’s utility when his or her total payoff is x, the manager’s expected 
utility can be expressed as    
   
0
( ) ( ) .U Z P f P dP
   (1) 
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 In this framework, we analyze a manager’s expected utility under different portfolios of stock and 
options. We assume the manager has a power utility function with a coefficient of relative risk aversion of 
two. Similar to the Black-Scholes model, we assume that the firm’s stock return follows a lognormal 
return process, and  following  Lambert et al. (1991), we assume an initial stock price of $50, annual 
expected return of 0.10 per year, and an annual variance of returns σ2.  
For simplicity, we analyze the manager’s expected utility under two possible portfolios: one with 
only options and the other with only stock. The options portfolio contains 50,000 options. The options are 
assumed to expire in ten years and have a 20 percent probability being in the money at expiration. The 
stock portfolio contains 2,500 shares of stock. The particular numbers of options and shares ensure that 
the two portfolios provide the manager with the same expected utility when at the risk level that 
maximizes expected utility; in other words, the manager’s participation constraint is satisfied equally by 
the two portfolios. In both cases, the portfolio accounts for one-third of the manager’s total wealth. We 
use a positive affine transformation to rescale the utility functions so that the maximum utility is equal to 
ten. Figure 1 plots the manager’s expected utility as a function of the firm’s stock return variance under 
the two different portfolios. 
The two expected utility functions in Figure 1 illustrate how options’ convex payoffs (vega) can 
influence the manager’s optimal level of risk-taking. As shown in Figure 1, the level of stock variance 
that maximizes a manager’s expected utility depends on the manager’s portfolio; the optimal stock 
variance for the manager with the options portfolio is greater than it is with the stock portfolio. The 
manager’s optimal stock variance is chosen to balance incentives from the payoff’s convexity and his or 
her risk aversion. For a given increase in risk, the increased value of a convex portfolio increases the 
manager’s expected utility, but risk aversion reduces it. At low levels of risk, the gains in expected utility 
from the portfolio’s convexity exceed the losses from risk aversion, providing a net incentive for the 
manager to take on greater risk. The prior literature has focused on this relationship between the amount 
of convexity in the payoff structure (vega) and the desired level of risk-taking.10  
                                                            
10 Although the options portfolio increases risk-taking incentives in this example, this need not always be the case.  
As shown by Lambert et al. (1991), Carpenter (2000), and Ross (2004), options—particularly those deep in-the-
money—also make a manager’s wealth sensitive to stock price movements (i.e., options also increase delta), which 
can reduce risk-taking incentives. 
10
 A portfolio’s convexity also affects the “risk-curvature” of the manager’s expected utility, where 
risk-curvature is defined as the manager’s marginal utility with respect to risk. For example, note the risk-
curvature of the manager’s expected utility around the optimal levels of risk in Figure 1; the expected 
utility of the manager with options is flatter around the peak than that of the manager with stock.  The 
difference in risk-curvature arises from the convexity-risk aversion tradeoff. An increase in volatility 
reduces a manager’s expected utility because the manager is risk averse, but convex compensation 
mitigates this reduction in expected utility because the convexity boosts the expected value of the 
compensation as volatility increases. The same intuition holds in reverse for reductions in volatility; a 
manager with more convex payoffs experiences smaller changes in expected utility when risk decreases.11 
Our paper exploits this novel connection between payoff convexity and risk-curvature to design 
an empirical test that links managers’ compensation convexity to risk-taking. Rather than examine the 
relationship between convexity (vega) and the level of risk-taking directly, as in the prior empirical 
literature, our identification strategy instead examines the relationship between convexity and the change 
in risk-taking after firms’ risk unexpectedly increases. Put in terms of the manager’s expected utility as a 
function of risk (Figure 1), we relate risk-taking behavior to convexity-driven differences in risk-
curvature at the peak rather than to convexity-driven differences in the location of the peak. Our thought 
experiment is as follows: assume that a manager has already chosen the level of risk that maximizes his or 
her expected utility given the current compensation arrangement; what happens when the firm’s risk 
environment unexpectedly changes?  
When the risk environment changes, the convexity of the manager’s potential payoffs also 
changes. Theoretically, the effect of an increase in left-tail risk on the convexity of an option’s payoff 
structure is ambiguous. The partial derivatives of vega with respect to volatility and stock price, where 
vega is measured as the sensitivity of the value of the managers’ options to stock price volatility 
(following Core and Guay, 2002), can be positive or negative depending on other parameters. Strictly 
                                                            
11 Like the effect of options on a manager’s desired level of risk, the effect of options on a manager’s sensitivity to 
deviations in risk is also theoretically ambiguous because options provide exposure to stock price movements (i.e., 
delta) in addition to convexity. In our example, the convexity effect dominates. 
11
 speaking, the stock portfolio’s convexity is also affected by the increase in tail risk, but the effect is small 
and will not be picked up by this definition of vega (Guay, 1999; Core and Guay, 2002).   
The convexity of the manager’s payoffs prior to the unexpected change in risk, however, is a 
positive predictor of convexity immediately after the change in risk. In Figure 2, we plot the vega for each 
portfolio after risk changes. To match our empirical setting, we model this change in risk as an increase in 
left-tail risk. (The analysis is similar when the increase in stock return variance is mean-preserving; see 
Appendix B). Specifically, we examine an increase in the probability of a stock price realization below 
$10; we plot the effect of increases in this probability of between zero and five percentage points. A five 
percentage point increase in the probability of a price below $10 roughly represents a doubling of that 
probability.12 Our analysis is robust to varying the size of the shock in both scope (the price below which 
realization probabilities increase) and scale (the size of the probability increase). As shown in Figure 2, 
the vega of the option portfolio declines after left-tail risk increases but remains greater than the vega of 
the stock portfolio, which equals zero irrespective of the tail-risk.   
This difference in the portfolios’ convexity affects risk-taking incentives after tail risk increases. 
Figure 3 plots the manager’s marginal expected utility with respect to volatility after left-tail risk 
increases. Marginal expected utility is plotted separately for the stock and option portfolios. The 
manager’s marginal expected utility is negative for both portfolios but is smaller in magnitude for the 
more convex portfolio. In other words, the convex portfolio provides the manager with less incentive to 
reduce the firm’s stock price volatility after risk increases. This difference in incentives relates to the risk-
curvature of expected utility around its peak and to the underlying convexity-risk aversion tradeoff. A 
risk-averse manager, irrespective of his or her portfolio, gains from reducing risk, but this gain is less 
when reducing risk also reduces the expected value of convex payoffs. If it is costly or simply difficult to 
adjust the firm’s risk, this effect of convexity makes the manager less responsive to the firm’s changing 
risk environment.  
                                                            
12 An increase in left-tail risk also reduces a firm’s overall value and stock price. In this example, a five percentage 
point increase in the probability of a price below $10 reduces the firm’s stock price by about 5.25%. 
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 As illustrated by Figures 2 and 3, the pre-existing differences in convexity largely persist after 
risk increases and affect managers’ risk-taking incentives. Our empirical tests, therefore, relate managers’ 
responses to their pre-existing pay structure. We measure their pay structure prior to risk unexpectedly 
increasing because these incentives are predetermined and highly correlated with their incentives 
immediately afterwards, which we do not observe directly in our empirical setting. The ex post vega and 
delta that we do observe might already be affected by managers’ endogenous responses, including 
adjustments to financial leverage, cash holdings, R&D, and acquisitions. By affecting firm risk, these 
managerial actions also affect the convexity of managers’ own payoff structure, thereby making it 
difficult to identify the direction of causality when relating managers’ actions to the ex post level of 
convexity.13  
By focusing on how vega is related to responses to unanticipated increases in risk, rather than 
absolute levels of risk-taking, our empirical approach allows us to avoid the concerns about reverse 
causality that plague the existing literature. Traditionally, researchers have compared the vega of 
managers’ portfolios to measures of firm risk, but as shown in Section 4, the firms’ risk environment 
influences boards’ choices regarding managers’ equity-based pay. Absent exogenous shocks to managers’ 
option-based incentives, this reverse causality poses an identification challenge for the traditional 
estimation approach. Because our approach focuses instead on how vega affects responses to increased 
risk, avoiding concerns about reverse causality only requires that the increase in risk be unanticipated.  
Thus, our approach to identify convexity’s effect on risk-taking requires the same assumptions as 
would be required to use the ex ante payoff structure as an instrument for the unobserved ex post payoff 
structure that motivates managers’ risk-taking:14 
1) The portfolio vega (portfolio delta) immediately prior to risk increasing is positively 
correlated with the portfolio vega (portfolio delta) immediately afterward. 
                                                            
13 Figures 2 and 3 also illustrate why it is appropriate to focus on ex post levels of vega rather than on the changes in 
vega caused by the increase in left-tail risk. Even though vega decreases more when the manager holds options 
(Figure 2), the manager has less incentive to reduce risk when he or she holds options (Figure 3), because the 
manager still has a higher vega after risk increases than when he or she holds stock.   
14 Note that we cannot use the increase in liability risk itself as an instrument for vega and delta, because the increase 
itself boosts stock volatility, thereby violating the exclusion restriction. 
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 2) The increase in left-tail risk is unanticipated. 
3) The portfolio vega and portfolio delta immediately prior to risk increasing are not 
correlated with variables that also affect companies’ responses to the increased risk. 
The first assumption allows us to use the ex ante portfolio vega and portfolio delta as proxies for the 
unobserved ex post portfolio vega and portfolio delta that drive risk-taking incentives. The second 
assumption enables us to rule out reverse causality, and the third assumption pertains to omitted variables. 
Unlike the traditional empirical approach, which must assume the absence of unobservable factors that 
affect both managers’ portfolios and firms’ risk, our assumption is narrower. In order for an unobserved 
variable to be problematic in our setting, it must affect both managers’ portfolios and how firms respond 
to unanticipated changes in risk. We evaluate and rule out potential confounders in robustness tests 
reported in Section 5.  
 
3. Empirical setting 
In this paper, we analyze left-tail risk that is created when a chemical to which a firm’s workers 
have already been exposed is newly identified as a carcinogen. The discovery increases both the liability 
and regulatory risks of the firm. Using data on workplace exposures to known carcinogens, historical 
damage awards, and historical cash flows, Gormley and Matsa (2011) find that a typical legal liability 
faced by firms with such workplace exposures is around 5% of assets, and that such a shock would 
increase the median probability of distress among exposed firms by 30-fold. The possibility that future 
regulation might limit the use of these chemicals and significantly increase a firm’s cost of doing business 
further increases the risk of future distress. See Gormley and Matsa (2011) for a more detailed description 
of the liability and regulatory risks associated with workplace exposures and why firms cannot easily 
insure or protect themselves from these risks. 
Identifying workers’ exposure to newly identified carcinogens requires the combination of 
information on (1) scientific discoveries related to chemical carcinogenicity and (2) which firms use these 
chemicals. Following Gormley and Matsa (2011), we use the National Toxicology Program’s (NTP) 
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 Report on Carcinogens (RoC) for information about the timing of discoveries and the National 
Occupational Exposure Survey (NOES) to identify firms in which workers were likely to have been 
exposed to these chemicals. We considered various other data sources, including International Agency for 
Research on Cancer monographs, California Proposition 65, and the Environmental Protection Agency’s 
Integrated Risk Information System. We chose to rely on the RoC because each edition is comprehensive, 
because it provides a long time series, and because U.S. law requires firms to monitor the list. For 
example, firms are required to warn employees about their exposure to substances that are included in the 
RoC [U.S. Government Regulation 29 CFR, parts 1910.1200(b)(1) and (d)(4)].  Although the RoC is not 
updated annually, Gormley and Matsa (2011) find that firms respond only after chemicals are added to 
the list.   
We determine whether a firm is affected by the listing of a newly classified carcinogen based on 
the firm’s SIC code in Compustat in the year prior to each new listing.15 We consider a firm to be affected 
if it operates in a 4-digit SIC code in which at least 5% of workers were observed to be exposed to the 
carcinogen in the NOES. The 5% cutoff captures 32 unique chemical additions to the RoC after 1983 and 
roughly the top third of observed exposures at the industry level, corresponding to the discoveries that are 
most likely to result in increased legal liability and future distress.16  
Our data on firms’ financials are from Compustat, and our data on executive compensation are 
from Yermack (1995) and Execucomp. Yermack (1995) covers the approximately 800 firms listed by 
Forbes magazine as among the 500 largest U.S. public corporations in the years 1984–1991, and 
Execucomp covers about 3,000 S&P 1,500 firms in the years 1992–2008. Our main measures of a CEO’s 
payoff structure are the sensitivities of the CEO’s firm-related wealth to stock price movements and to 
stock price volatility. We calculate a manager’s sensitivity to stock price movements (delta) from his or 
her portfolio of stock and options using the Core and Guay (2002) definition—the dollar change in wealth 
                                                            
15 To accomplish this, we first convert the NOES data, which are reported using the SIC-1972 coding scheme, to the 
SIC-1987 coding scheme used by Compustat, by applying an employee-weighted concordance table from the 
Bureau of Labor Statistics (1989). We then determine which firms were affected by an increase in tail risk based on 
Compustat’s historical measure of a firm’s industrial classification.  
16 We use a lower cutoff than do Gormley and Matsa (2011) because of the relatively small number of exposed firms 
for which compensation data are available.  
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 experienced by the manager for a 1% increase in the firm’s stock price. We calculate the sensitivity to 
stock price volatility (vega) using the dollar change in wealth experienced by the manager for a 0.01 
increase in the volatility of a firm’s stock price. This measure of sensitivity has been used to measure a 
manager’s incentive to take risks (e.g., Guay, 1999; Habib and Ljungqvist, 2005). Both incentive 
measures are expressed in thousands of dollars. Details on the construction of all variables are in 
Appendix A. 
To ensure a consistent sample of observations across specifications, we exclude observations with 
missing values for the inputs necessary to calculate the manager’s delta and vega in the year prior to a 
chemical being added to the RoC. In all, 143 firms with both financial and compensation data are affected 
by a newly identified carcinogen, and these increases in tail risk occur for different firms in 1985, 1989, 
1991, 2000, and 2004. These firms operate in 43 different 4-digit SIC industries and span 21 of the 48 
Fama and French (1997) industries. (Fama-French industries are collections of 4-digit SIC industries that 
are meant to represent broader industry categories.) 
For each new chemical listing in the RoC, we construct a comparison group of unaffected firms 
(firms without observed exposures to any newly listed carcinogens) that were present in the same Fama- 
French industry classification as one of the affected firms. To ensure an adequate control sample in each 
industry, we drop both affected and unaffected observations in Fama-French industries in which there is 
not at least one unaffected firm for every ten affected firms. (Our findings are robust to using other 
exclusion thresholds.)  This yields a comparison sample of 341 unexposed firms in 82 SIC industries.  
Firms with exposures to the newly identified carcinogens are strikingly similar to our sample of 
unexposed firms before the listing of a new carcinogen. Ex ante characteristics of firms with exposures 
are reported in column (1) of Table 1, and the ex ante characteristics of firms without exposures are 
reported in column (2). Even though we match firms based only on Fama-French industries, the two 
groups are similar in average stock variance, size, market-to-book, and profitability. Annual 
compensation and equity-based incentives, as measured by log total pay and the fraction of pay given as 
options, are also similar across the two groups of firms. The differences in delta and vega of managers’ 
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 full portfolio of options and stock are less than one-tenth and one-eighth of a standard deviation, 
respectively.17 As shown by the p-values reported in column (3), we are unable to reject the null 
hypothesis that exposed and unexposed firms are similar in all of these dimensions before risk increases. 
As in Gormley and Matsa (2011), the use of the NOES likely introduces a degree of measurement 
error in our ability to identify firms with potential exposures, possibly leading us to underestimate the true 
effect of tail risk. There are two main measurement issues. First, the NOES only provides data on 
exposures at the 4-digit industry level; firm-level data is not available. Our subsequent analysis implicitly 
assumes that all firms in the industry are affected and calculates the average effect. If not all firms in the 
industry are affected, then we are underestimating the true average effect of the increase in tail risk. 
Second, firms may have stopped using a dangerous chemical after the NOES was completed in 1983 but 
before the chemical’s listing in the RoC. Whereas firms would still be liable for past exposures, the 
increase in liability risk would be smaller in such cases. Despite these measurement concerns, Gormley 
and Matsa (2011) present evidence to suggest that the NOES indeed captures exposures that later become 
significant liability and regulatory risks.      
An analysis of firms’ stock volatility suggests that the liability and regulatory risks associated 
with these exposures are salient. Figure 4 plots the annualized daily variance of exposed and unexposed 
firms’ stock returns, relative to the year before a new chemical is added to the RoC. Whereas exposed and 
unexposed firms’ stock variances track each other quite closely before the carcinogen comes to light, they 
diverge sharply afterward with stock variance increasing by about 60% among exposed firms. The sharp 
change in volatility after a chemical is added to the RoC confirms that new RoC listings correctly capture 
the timing of increases in business risk. 
Gormley and Matsa (2011) analyze corporate responses to this increase in risk. They find that 
firms, especially those with weak balance sheets, tend to respond to such risks by acquiring large, 
unrelated businesses with relatively high operating cash flows. The diversifying growth is primarily 
funded with equity, thereby reducing overall financial leverage, and appears to be motivated primarily by 
managers’ personal exposure to their firms’ risk in that the growth has negative announcement returns 
                                                            
17 The standard deviations of portfolio delta and portfolio vega are 2,179 and 120.8, respectively. 
17
 and is related to firms’ external governance, institutional ownership, and inside ownership, as measured 
using the share of the firm’s stock held by the firm’s management team. The analysis here directly 
examines the role of CEOs’ compensation, its convexity, and its effect on risk-taking incentives. In 
particular, we examine how quickly boards change the structure of CEOs’ compensation to reflect the 
new risk environment, and we exploit CEOs’ pre-existing stock and options holdings (that were awarded 
before the manifestation of the tail risk) to analyze whether the convexity of managers’ payoff structure is 
related to risk-taking incentives.   
4. How business risk affects the structure of managerial compensation 
To examine how compensation structures respond to increased tail risk, we compare changes in 
the exposed and unexposed firms’ managers’ compensation structures after a new carcinogen is listed in 
the RoC. We first analyze the immediate impact of business risk on the structure of managers’ annual 
compensation (which we will refer to as compensation “flows”) and on managers’ decisions to exercise 
options. We then analyze the long-term impact on managers’ overall portfolio vega and portfolio delta 
and the impact on the starting-year vega and delta of newly hired managers. 
 
4.1. Effects of exposure on flow vega, flow delta, and options exercised   
To examine how the structure of compensation flows respond to increased tail risk, we construct 
a cohort of exposed and unexposed firms using firm-year observations for the three years before and the 
three years after the listing for each year that new carcinogens are listed. We start with three-year 
windows to examine how compensation changes in the immediate aftermath of the increase in tail risk. 
Firms are not required to be in the sample for the full six years around the listing. We then pool the data 
across cohorts (i.e., across all new carcinogen listings) and estimate the average treatment effect using a 
stacked difference-in-differences estimation similar to Gormley and Matsa (2011). Specifically, we 
estimate the following firm-panel regression:        
 0 1 ,        flowijct jct tc ic ijctIncentives Exposure  (2) 
where flowijctIncentives  is one of several dependent variables of interest related to the structure of the chief 
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 executive’s compensation flow for firm i in year t, and Exposure is an indicator that equals one if at least 
5% of employees in cohort c and industry j were observed to be exposed in the NOES to a known RoC-
listed carcinogen as of year t. For an exposed firm, this indicator changes from 0 to 1 when the chemical 
is identified as a carcinogen. We include firm-cohort fixed effects,ic , to ensure that we estimate the 
impact of exposure after controlling for any fixed differences between firms; we include year-cohort fixed 
effects, tc , as a non-parametric control for any secular time trends. Gormley and Matsa (in press) show 
that such fixed effects, rather than other ad hoc transformations of the dependent variable commonly used 
in the literature, are the correct way to control for unobserved group heterogeneities. We allow the firm 
and year fixed effects to vary by cohort because this approach is more conservative than including simple 
fixed effects. In our baseline specification, we deliberately do not control for any time-varying accounting 
variables because these variables are likely to be affected by the increase in tail risk, and their inclusion 
could thus confound estimates of 1 .18 In any event, the results are robust to the inclusion of standard 
controls, as reported in the tables below. To account for potential covariance among firm outcomes within 
the same 4-digit SIC code and over time, we adjust the standard errors for clustering at the industry level.  
After tail risk increases, there are two primary ways for a manager’s financial exposure to the 
firms’ stock price and volatility to change: changes initiated by the company’s board and changes 
initiated by the manager. First, the board can modify the options and stock components of the manager’s 
current pay. We measure these adjustments using the vega and delta of managers’ current year 
compensation and refer to these sensitivities as “flow vega” and “flow delta” for short. Second, the 
manager can modify his or her exposure by exercising vested options and/or selling unrestricted stock. 
We examine both types of changes in Table 2. 
We find that boards do in fact modify the incentive structure of managers’ annual compensation 
after tail risk increases. Specifically, they reduce the annual compensation’s sensitivities to both return 
volatility and price. Controlling only for firm-cohort and year-cohort fixed effects, the CEOs’ flow vega 
                                                            
18 Because the increase in tail risk is exogenous, β1 in Eq. (2) measures the change in the dependent variable caused 
by the increased tail risk. If we include endogenous controls, then β1 might be biased (Angrist and Pischke, 2009, 
pp. 64–66). 
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 decreases, on average, by $7,600 per 0.01 increase in the firm’s stock return volatility (column 1; p < 
0.05), and the flow delta decreases by about $12,900 per 1% increase in equity value (column 4; p < 
0.01). The declines in flow vega and flow delta are robust to additional controls for firm size, CEO tenure, 
and the CEO’s total cash compensation (columns 2 and 5).19 These decreases are also not driven by CEO 
turnover; significant drops in both flow incentives remain after excluding ex post observations from both 
the affected and comparison samples for which a different CEO is in control than in the year before the 
listing (columns 3 and 6).  
The declines in vega and delta are consistent with boards responding to the decline in risky 
investment opportunities that shareholders wish to pursue. Because the increase in left-tail risk reduces 
the expected cash flows from many risky investments, boards have reason to use less convex payoffs and 
fewer stock-based incentives. The declines could also reflect other considerations, as discussed in Section 
2.1.20 
Managers of exposed firms also take actions to directly reduce their own financial exposure to 
their firms’ risk. In the three years after tail risk increases, CEOs of exposed firms sharply increase the 
value of options they exercise relative to CEOs of unexposed firms by more than $1 million, after 
controlling for size, tenure, and cash compensation (column 8; p < 0.01). The increase in the value of 
options exercised is robust to excluding observations for which a different CEO is present than in the year 
before the RoC listing (column 9). In unreported results, we also find a decrease in the number of shares 
owned by managers of exposed firms of about 30,000, suggesting these managers may be selling shares 
in addition to exercising options, but the estimate is noisy and not statistically significant (the standard 
error is about 85,000 shares).         
                                                            
19 Our control variables in this and later specifications follow Hayes et al. (2012). All of the variables are defined in 
Appendix A. 
20 Some caution is warranted before interpreting the decline in convexity after risk increases as evidence that boards 
in our sample want CEOs to engage in risk-reducing activities, like diversifying acquisitions, rather than just to 
curtail future investments. Further analysis finds that the reduction in vega is greater among managers with an 
above-median vega. Even after the reductions, these managers’ average vega remains higher than that of other 
exposed firms and discourages these managers from engaging in the value-destroying, risk-reducing activity 
documented in Gormley and Matsa (2011).   
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 The timing of these changes coincides with the increase in tail risk. Figure 5 plots point estimates 
from a modified version of Eq. (2), where we allow the effect of Exposure to vary by year from three 
years before risk increases until three years afterward.21 The relative changes in flow vega (flow delta) are 
in the top (middle) panel. There is no indication of a decrease in flow vega or flow delta prior to the 
increase in tail risk, but afterward, firms with exposure to a newly identified carcinogen tend to reduce 
their CEO’s flow vega and flow delta relative to other firms. These reductions begin the year risk 
increases and stay lower thereafter. 
The timing of the increase in options exercised by managers at exposed firms, presented in the 
bottom panel of Figure 5, is striking as well. The value of options exercised is practically flat in the years 
before tail risk increases; before the chemical is added to the RoC, managers of exposed firms appear no 
more likely than do managers of other firms to increase or decrease the number of options exercised. 
Then as soon as risk increases, managers of firms with exposure to a newly identified carcinogen start 
exercising options more than do other managers. These managers exercise an additional $2 million in 
options relative to managers of similar unexposed firms in the year that risk increases and exercise an 
additional $1 million the following year.  
The precise timing of these exercise decisions and the changes in flow vega and flow delta 
suggest that they are in fact caused by the increase in tail risk, rather than by any omitted characteristic 
related to the manager, firm, or industry. The timing of these changes also confirms that firms and their 
managers did not anticipate the chemicals’ addition to the RoC; if anticipated, we would expect the 
incentive changes and option exercising to begin prior to the chemical being added to the RoC. 
These findings highlight the potential for reverse causality in prior studies of CEO incentives and 
their effect on corporate risk-taking. A firm’s choice to use stock- and option-based incentives depends on 
its risk environment, so a correlation between equity-based incentives and firm risk may reflect the effect 
of the firm’s risk environment on its choice of incentives or vice versa. This joint determinedness of 
incentives and a firm’s risk raises concerns about previous identification strategies that implicitly or 
explicitly assume the firm’s risk environment has no effect on the choice of incentives. 
                                                            
21 This analysis examines a longer panel of five years before Exposure. The point estimates reported in Figure 5 are 
estimated relative to the excluded years T – 4 and T – 5.  
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4.2. Long-term effects of exposure on portfolio vega and portfolio delta  
We next analyze the long run changes in the vega and delta of managers’ accumulated 
compensation portfolios—what we call the “portfolio vega” and the “portfolio delta.” Table 3 presents 
results from regressions examining the overall change in portfolio vega and portfolio delta in the years 
after risk increases. Specifically, we estimate the following firm-level regression:      
  [ ] [ 1] 1 [ ]          portfolio portfolioijc t T k ijc t T jc t T k c ijcIncentives Incentives Exposure ,  (3) 
where [ ] [ 1]   portfolio portfolioijc t T k ijc t TIncentives Incentives  is the change in portfolio vega or portfolio delta from the year 
before a chemical is added to the RoC (i.e., t = T - 1) to k years after the chemical is added (t = T + k) 
for the CEO of firm i in industry j and cohort c; Exposurejc[t=T+k] is defined as before; and δc  is a cohort 
(or, equivalently, year) fixed effect. To focus on how the shift in flow vega, flow delta, and exercising 
activity affect the portfolio vega and portfolio delta of the existing CEO, we exclude observations in 
which the CEO in year T + k was not in office in year T - 1. We analyze the change in portfolios for 
newly appointed CEOs below. The standard errors are again adjusted for clustering at the industry level. 
We find that the changes in the composition of new compensation awards and in managers’ 
exercising behavior seem to lower CEOs’ portfolio vega or portfolio delta three years after tail risk 
increases, but the declines are not statistically significant. Our point estimate for the three-year decrease 
in portfolio vega is about $25,000 per 0.01 increase in a firm’s stock volatility, which is about one-fifth of 
a standard deviation (Table 3, column 1). The three-year decrease in portfolio delta is about $180,000 per 
1% increase in equity value, or about one-fourth of a standard deviation, for managers of exposed firms 
relative to other managers and relative to their own deltas before risk increases.  
Decomposing the exposed firms’ vega after risk increases illustrates the sources of these changes 
and the relative importance of already-granted stock and options. CEOs’ portfolio vega after tail risk 
increases can be written as the combination of three components:    
 [ ] [ ] [ ] [ ]         portfolio pre flow exercisedijc t T k ijc t T k ijc t T k ijc t T kvega vega vega vega , (4) 
where [ ] preijc t T kvega  is the vega in year T + k of the compensation portfolio held by CEO i in industry j and 
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 cohort c in year T – 1, [ ] flowijc t T kvega  is the vega of options accumulated through the CEOs’ annual 
compensation flows between years T and T + k, and [ ] exercisedijc t T kvega  is the vega of options exercised by the 
CEO between years T and T + k. To estimate how much each of these sources contribute to the changes in 
vega, we restrict attention to the Execucomp sample, due to data availability. Further details on these 
calculations are in Appendix C. 
We find some evidence of exposed CEOs’ portfolio vega decreasing after risk increases, similar 
to our findings in the full sample.  Figure 6, Panel A plots the average portfolio vegas for managers of 
exposed and unexposed firms. While there appears to be no change in portfolio vega among unexposed 
firms over the period, the exposed firms’ portfolio vega drops in the year that tail risk increases and 
continues to decrease in subsequent years. The cumulative decline in year T + 2 is about one-third of a 
standard deviation, but similar to the full sample (reported in Table 3, Column 1), it is not statistically 
significant at conventional levels (p = 0.15).   
The breakdown of the portfolio vega into its three components reveals the importance of 
managers’ pre-existing portfolio after tail risk increases. As shown in Panel B of Figure 6, the pre-existing 
portfolio still accounts for almost half of exposed CEOs’ portfolio vega three years after tail risk 
increases. The continued importance of the pre-existing portfolio may not be surprising in that vesting 
schedules restrict managers’ ability to exercise their options and because it is costly for firms to modify 
securities that have already been awarded. The ongoing influence of the pre-existing portfolio suggests 
that the decline in flow vega and flow delta described above take time to significantly affect the portfolio 
vega and portfolio delta.  
The breakdown shown in Figure 6, Panel B, however, does not allow us to ascertain what 
proportion of the average drop in portfolio vega is driven by each of the three components. For example, 
does the pre-existing portfolio vega decline at a greater rate or do vega flows accumulate more slowly? 
To answer this question, we construct a counterfactual of what the three components would have been 
absent the increase in risk. The counterfactual assumes that managers exercise the same number of 
options as in year T – 1 and that the pre-existing portfolio vega and the flow vega change at the same rate 
as for unexposed firms.    
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 Relative to this counterfactual, we find that the newly granted compensation’s lower vega 
increasingly contributes to the average decline in vega over time. The estimates are displayed in Figure 6, 
Panel C. We attribute about a third of the observed drop in CEOs’ portfolio vega three years after the 
increase in left-tail risk to the decline in CEOs’ pre-existing portfolio vega, about 60% to the reduction in 
annual flows, and about 6% to increased options exercising.22 The relative contribution of each source 
varies over time. In the first year, more than half of the decline in portfolio vega is from the CEOs’ pre-
existing portfolio, while only about one-third is from the flow vega and 10% is from the increased 
exercising.  
This diminishing role of the pre-existing portfolio suggests that the reduced flow vega and flow 
delta have greater impacts over time. Table 3 reports longer-term changes in portfolio vega and portfolio 
delta. We find a statistically significant decline in managers’ portfolio delta beginning in year four. In the 
fourth year after tail risk increases, the portfolio delta is about $350,000 per 1% increase in equity value 
lower for managers of exposed firms relative to other managers and relative to their own deltas before 
risk increases (column 4; p < 0.05). This decline is about half of a standard deviation in exposed firms’ 
portfolio delta. By the fifth year, portfolio delta decreases by about $450,000 per 1% increase in equity 
value (column 6; p < 0.10). Beginning in the sixth year after tail risk increases, we also find a statistically 
significant decline in portfolio vega. The six-year change in portfolio vega is about $55,000 per 0.01 
increase in a firm’s stock volatility, which is about 40% of a standard deviation for exposed firms 
(column 7; p < 0.10). 
 
4.3. Effects of exposure on the vega and delta of newly-hired managers           
If a manager’s existing portfolio impedes his or her portfolio incentives from adjusting quickly, 
then one would expect portfolio incentives for new CEOs to exhibit a different pattern. Because new 
CEOs typically enter these positions with relatively small portfolios of company stock and options, their 
portfolio incentives should respond quickly after risk increases. To analyze this, we estimate a 
                                                            
22 The positive contribution of the existing portfolio to the decline in vega indicates that, on average, the increase in 
stock volatility and decrease in stock price caused by the increase in left-tail risk cause a drop in the portfolio vega 
of exposed CEOs relative to the drop observed for unexposed CEOs.  This is consistent with the decline in vega 
observed in the theoretical example for a CEO with options (see Figure 2). While not presented in Figure 6, we also 
find that the increase in left-tail risk reduces the average delta of CEOs’ pre-existing portfolios. 
24
 specification similar to Eq. (2) using only observations from new CEOs’ first year. This estimation 
indicates whether Exposure is associated with different initial incentives for new CEOs. Because there are 
not many firms with a new CEO in the three years both before and after tail risk increases, we do not 
include firm-cohort fixed effects in these specifications. To control for possible baseline differences in the 
portfolios of newly hired CEOs in exposed and unexposed industries, we include an indicator variable for 
industry-cohorts that experience an increase in tail risk. The results are reported in Table 4. 
After tail risk increases, newly hired CEOs are given compensation portfolios that exhibit lower 
exposure to firm risk. The portfolio vega is almost $50,000 lower, or about a third of a standard deviation, 
for a 0.01 increase in the standard deviation of stock returns for newly hired CEOs of exposed firms 
relative to other newly hired CEOs (column 1; p < 0.10). The lower portfolio vega is robust to controlling 
for firm size, cash compensation, and CEO tenure (column 2; p < 0.10).   
 After risk increases, new CEOs of exposed firms are also paid with lower vegas than are the 
CEOs they replaced. To examine within-firm changes, we compare the portfolio vega of the new CEO 
with that of the prior CEO. Columns 3 and 4 of Table 4 present results for the difference in portfolio vega 
between the new CEO and the prior CEO. After controlling for changes in firm size, cash compensation, 
and CEO tenure, the portfolio vega of a newly hired CEO of an exposed firm is about $85,000, or almost 
two-thirds of a standard deviation, lower than that of the previous CEO, relative to the change at 
unexposed firms (column 4; p < 0.10).  
5. How the structure of managerial compensation affects corporate risk-taking 
Our finding that CEOs’ portfolios respond to changes in firms’ risk environment highlights a key 
challenge in identifying a causal effect of incentives on corporate risk-taking. A correlation between 
managers’ portfolio convexity and firm risk could reflect the effect of the convexity on managers’ risk-
taking or it might reflect the effect of firms’ background risk on boards’ choices regarding pay.  
The unanticipated increase in tail risk provides an opening to overcome this identification 
challenge. To the extent that managers are motivated by financial incentives, portfolio vega and portfolio 
delta affect responses to the increase in risk. As shown in Section 2.2, risk-averse managers with convex 
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 payoff structures will have less to gain from reducing risk since doing so will also decrease the expected 
value of their convex payoffs. Using the ex ante vega as a proxy for the (unobserved) vega managers face 
after risk increases but before they respond, we are able to identify an effect of convexity on risk-taking 
incentives that avoids the reverse causality critique.23     
To analyze the relationship between incentives and risk-taking, we augment our estimation 
framework to allow for a differential effect of exposure based on managers’ portfolio vega and portfolio 
delta in the year before tail risk increases. Given the persistence of portfolio vega and portfolio delta (see 
section 4.2), we focus on a short window of three pre-risk and three post-risk years, and exclude any firm-
years after a CEO turns over to ensure the pre-determined compensation structure is a valid proxy for the 
ex post incentives. Specifically, we estimate the following firm-panel regression:     
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 (5) 
where yijct is one of several dependent variables of interest related to corporate risk-taking, Vegaijc[t=T – 1]  
and Deltaijc[t=T – 1] correspond to managers’ portfolio delta and portfolio vega in the year prior to tail risk 
increasing, and Exposure and the various fixed effects are defined as above. To ease the interpretation of 
the estimates, Vegaijc[t=T – 1] and Deltaijc[t=T – 1] are normalized by their sample standard deviations and 
demeaned with respect to their sample means before they are interacted with Exposure (i.e., 
( ) ( ) /X XX X    ). Therefore, λ1 represents the effect of exposure on a firm with average portfolio 
vega and average portfolio delta, and λ2 (λ3) represents the incremental effect of exposure for a standard 
deviation increase in vega (delta). The standard errors are again adjusted for clustering at the industry 
level. 
We include both vega and delta in the specification to disentangle option grants’ competing 
effects on risk-taking incentives. On one hand, options’ convex payoffs can encourage risk-taking 
because the manager shares all of the gains with shareholders but not all of the losses (Jensen and 
Meckling, 1976; Myers, 1977; Smith and Stulz, 1985; Haugen and Senbet, 1981; Smith and Watts, 1992; 
                                                            
23 We cannot directly observe the incentives immediately after the increase in left-tail risk because we only observe 
the year, and not the exact day, in which left-tail risk increases.   
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 Gaver and Gaver, 1993; Bizjak et al., 1993; Guay, 1999; Core and Guay, 1999). Vega—the sensitivity to 
stock volatility—provides a measure of this convexity. On the other hand, holding options also increases 
a manager’s sensitivity to stock price movements—delta—and to the firm’s tail risk, which can 
discourage risk-taking (Lambert et al., 1991; Carpenter, 2000; Ross, 2004). Because the portfolio vega 
and portfolio delta are likely to be positively correlated, a failure to control for a manager’s portfolio delta 
may confound the effect we are interested in—the effect of options-based convexity on risk-taking after 
the increase in tail risk.  
The inclusion of firm-cohort fixed effects, ic , controls for time-invariant factors, like the 
managers’ risk tolerance, that might be correlated with the predetermined levels of vega and delta.  
Because we exclude observations after CEOs exit, these fixed effects also effectively control for manager 
fixed effects. We do not report estimates for the main effects, Vegaijc[t=T – 1] or Deltaijc[t=T – 1], because they 
are, by construction, time-invariant and perfectly collinear with the firm-cohort fixed effects. The 
coefficient on Exposurejct×Vegaijc[t=T – 1] captures the differential response for high-vega versus low-vega 
exposed firms relative to the similar differential response for unexposed firms. The Exposurejct× 
Deltaijc[t=T – 1] coefficient has an analogous interpretation. 
We first examine stock variance as a summary measure of firms’ risk-taking. A firm’s stock 
variance captures both exposed firms’ increase in tail risk and any corporate choices, such as lower 
leverage and fewer R&D expenditures, that offset this increase in risk. The estimates are reported in Table 
5. On average, the increase in tail risk is associated with a 0.10 increase in variance for firms with an 
exposure (column 1). The increase is large in magnitude (almost half of the sample mean and about a 
third of the sample standard deviation) and statistically significant when we add time-varying controls for 
firms’ size, leverage, R&D expenditures, and market-to-book ratio (column 3; p < 0.10).24  
The increase in firms’ risk is significantly larger among firms whose manager had a high 
portfolio vega before the increase in left-tail risk. A one standard deviation increase in a manager’s 
portfolio vega is associated with a 0.05 larger increase in stock variance after a chemical is added to the 
                                                            
24 The sample mean stock variance is 0.23 with a standard deviation of 0.29. The sample mean stock volatility, 
another measure of firms’ risk, is 0.42 with a standard deviation of 0.22. These summary statistics are similar to 
those of the samples analyzed in other papers (e.g., Hayes et al., 2012). 
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 RoC. Given that there is no reason to expect the increase in liability and regulatory risk from workplace 
exposures to be larger for firms with a higher ex ante vega, this finding suggests that managers with more 
convex payoffs are less likely to take actions to offset the unanticipated increase in left-tail risk.  
The larger increase in firms’ risk among managers with a high portfolio vega appears to result 
from a smaller reduction in financial and investment risk following the increase in tail risk. In analysis 
reported in Table 6, we examine firms’ leverage and cash management policies as a function of their 
managers’ incentives. The increase in tail risk is associated with a reduction in leverage for the average 
firm (column 1), but the decline is only statistically significant for firms with a low vega manager;25 a one 
standard deviation increase in a manager’s portfolio vega is associated with about a 1 percentage point 
smaller reduction in leverage (column 2; p < 0.10).  
Firms’ cash holdings also exhibit a differential response based on the convexity of managers’ 
payoffs. For the average firm, the increase in tail risk is associated with an increase in the ratio of cash to 
assets (column 4; not statistically significant), and a lower portfolio vega is associated with a larger 
increase in cash holdings (column 5; p < 0.01). This differential buildup in cash is robust to including 
controls for firms’ size, leverage, R&D expenditures, and market-to-book ratio (column 6), but the 
differential response in leverage is no longer statistically significant with controls for firms’ size, 
profitability, and R&D expenditures, and property, plant, and equipment (column 3).26 The association 
between portfolio delta and risk-taking after the increase in tail risk is the opposite. A higher delta is 
associated with a larger reduction in leverage (columns 2–3) and larger increase in cash holdings 
(columns 5–6).27  
Firms’ investment policies also appear to be affected by the CEO’s portfolio incentives. In 
analysis reported in Table 7, we examine firms’ research and development expenditures and acquisition 
                                                            
25 Gormley and Matsa (2011) find that the decline in leverage is statistically significant for the average Compustat 
firm. The estimate here is not statistically significant because our sample size is considerably smaller, as our analysis 
also requires data on the CEOs’ compensation portfolios.  
26 Again, our choice of controls in all specifications follows Hayes et al. (2012). Still, caution is warranted when 
interpreting estimates from specifications that include these endogenous controls, because their inclusion can 
confound the true causal effect (see footnote 18).   
27 The findings for portfolio delta are consistent with Gormley and Matsa (2011), who find that larger inside 
ownership, as measured by the fraction of shares owned by top managers, is associated with greater risk-reducing 
activities after tail risk increases.  
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 behavior. The results further highlight the importance of convexity. We find that the increase in tail risk is 
only weakly associated with a reduction in the ratio of R&D expenses to assets for the average firm, but a 
lower portfolio vega is strongly associated with a larger reduction in R&D expenses (column 2; p < 0.01). 
We also find that the portfolio vega is negatively associated with making diversifying acquisitions after 
risk increases. Gormley and Matsa (2011) find diversifying acquisitions to be a primary way firms reduce 
risk after such an event. Managers with a one standard deviation higher portfolio vega are 2.5 percentage 
points less likely to make a diversifying acquisition each year after tail risk increases. Both of the 
differential responses in R&D and diversifying acquisitions are robust to including additional time-
varying controls (columns 3 and 6; p < 0.01) and are consistent with options’ convex payoffs making 
CEOs less aggressive in cutting back on risky investments (such as R&D) and in increasing risk-reducing 
investments (such as diversifying acquisitions) after the jump in tail risk. 
One possible concern with these results is that an omitted variable could be related to both a 
manager’s ex ante incentive structure in the year before risk increases and the firm’s response afterward. 
Our analysis of managers’ compensation structures prior to the jump in tail risk relies on the assumption 
that the differences in compensation contracts, among firms which are otherwise comparable (as shown in 
Table 1), are not driven by factors that also affect firms’ responses to the increase in risk. Contracts will 
differ between comparable firms because these contracts are chosen to satisfy many objectives in addition 
to setting incentives for risk-taking. For example, some firms may choose to grant more options for 
accounting reasons (Hayes et al., 2012). These other objectives provide ex ante variation in incentives that 
we exploit. But if factors correlated with these objectives also affect firms’ response to a jump in risk, 
then our analysis might suffer from an omitted variable bias.  
We evaluate a wide range of potential omitted variables, including corporate financial 
vulnerability, external governance, and CEO age and tenure. Gormley and Matsa (2011) find that firms 
with greater ex ante bankruptcy risk (as measured by Altman’s z-score), smaller size, more leverage, 
lower cash flows, and no dividends are more likely to engage in diversifying growth after tail risk 
increases, presumably because these firms experience larger increases in the likelihood of distress. 
Gormley and Matsa also find differences related to firms’ external governance, including the proportion 
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 of institutional ownership. If these factors are related to the initial choice of compensation structure, then 
they—rather than incentives from the compensation—might possibly explain our findings. For example, 
older and more seasoned executives may be better equipped to cope with a major shock to the firm’s cash 
flows; perhaps it is simply these CEOs for which we see no meaningful risk-reducing activities?         
To examine the sensitivity of our results to these possible omitted variables, we repeat our 
analysis of Eq. (5) for stock variance, cash, leverage, R&D, and diversifying acquisitions but now include 
additional interactions between Exposure and the aforementioned list of potential omitted variables. 
Specifically, we include interactions between Exposure and firms’ size, leverage, modified Altman’s z-
score, cash flows, institutional ownership, CEO tenure, CEO age, and an indicator for paying dividends; 
similar to the portfolio vega and portfolio delta, each of the interacted variables is measured as of the year 
prior to the increase in tail risk. The estimates are reported in Table 8.  
There is no evidence that these potential omitted variables explain the observed correlation 
between portfolio vega and risk-taking activities following the jump in tail risk. A higher portfolio vega is 
still associated with larger increases in overall firm risk, as measured by stock variance (column 1; p < 
0.10), a smaller increase in cash holdings (column 2; p < 0.01) and diversifying acquisitions (column 5; p 
< 0.01), and a smaller reduction in leverage (column 3; p < 0.10) and R&D (column 4; p < 0.01).  
A final possibility, which we cannot completely control for directly, is that unobservable 
differences in managerial risk preferences explain the differential effect of vega on risk-taking. For 
example, it is possible that risk-tolerant managers match with riskier firms that also happen to provide 
more convex payoff schemes (Graham et al., 2013). If true, then it is possible that the underlying risk-
tolerance of the CEO, rather than convexity of his or her incentives, explains the importance of portfolio 
vega for the observed responses.  
Although we cannot rule out this possibility definitively, there are indications that it is unlikely to 
explain our findings. The robustness tests in Table 8 already allow for a differential effect of Exposure 
based on various measures of firm risk, including leverage, Altman’s z-score, and dividends. If the 
interaction between vega and Exposure is being driven by some matching of risk-tolerant managers to 
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 riskier firms, then we would expect these additional interactions to dampen the effect of vega; they do 
not. Moreover, theory suggests that the optimal contract for managers with greater risk aversion is 
actually more convex so as to provide incentives for the agent to take on appropriate risk on behalf of the 
more risk-tolerant shareholders (see, e.g., Guay, 1999). If true and if unobservable risk preferences were 
driving our observed responses, we would expect to find vega associated with more risk-reducing 
activities after tail risk increases. Instead, we observe the opposite.  
 
6. Conclusions and implications 
Every firm is exposed to business risks, including the possibilities of large, adverse shocks to 
cash flows. Potential sources for such shocks abound—examples include disruptive product innovations, 
the relaxation of international trade barriers, and changes in government regulations. We study (1) how 
boards adjust CEOs’ exposure to their firms’ risk after the risk of such shocks increase and (2) how 
incentives given by the CEOs’ pre-existing portfolios of stock and options affect their firms’ response to 
this risk. Specifically, we study what happens when a firm learns that it is exposing workers to 
carcinogens, which increase the risks of significant corporate legal liability and costly workplace 
regulations.  
The results presented in this paper suggest that corporate boards respond quickly to changes in 
their firms’ business risk by adjusting the structure of CEOs’ compensation, but that the changes only 
slowly impact the overall portfolio incentives CEOs face. After the unexpected increase in left-tail risk, 
corporate boards reduce CEOs exposure to their firms’ risk; the sensitivities of the flow of managers’ 
annual compensation to stock price movements and to return volatility decrease. Various factors likely 
contribute to the board’s decision, including CEOs’ reduced willingness to accept a large exposure to 
their firms’ risk and the decline in shareholders’ desired investment after left-tail risk increases. Indeed, 
managers act to further reduce their exposure to the firm’s risk by exercising more options than do 
managers of unexposed firms. These changes, however, only slowly move CEOs’ overall exposure to 
their firm’s risk because the magnitude of their pre-existing portfolios continues to influence their 
financial exposure to the firm.  
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 The unanticipated increase in business risk also provides an opportunity to analyze options’ 
causal effect on corporate risk-taking. We use CEOs’ pre-existing portfolio of options and stock as a 
proxy for managers’ portfolio immediately after the carcinogens’ discovery; these incentives are pre-
determined with respect to the new risk environment and not subject to the reverse causality concerns that 
plague existing studies of compensation structure and risk. We find that CEOs with more convex payoffs 
tend not to offset the unexpected increase in risk through diversifying acquisitions, reducing leverage, 
cutting R&D expenditures, or by building up greater cash holdings. As a result, stock variance increases 
the most for high vega firms after the jump in tail risk. The findings are robust to numerous robustness 
checks and do not appear to be driven by omitted factors that might affect both the choice of 
compensation and firms’ responses to the increased risk. 
Overall, our results show that options affect corporate risk-taking and highlight the importance of 
a board structuring its executives’ compensation packages to induce the desired level of risk taking. In 
addition, our results imply the novel insight that boards should design the convexity of managers’ 
compensation with an eye on potential changes in the company’s risk environment and how their 
executives will respond given their compensation. As our findings illustrate, more convex payoffs can 
dampen managerial incentives to offset unanticipated increases in business risk. Boards interested in 
encouraging more aggressive responses to future increases in business risk should use less convex 
payoffs, whereas other boards should use more convex payoffs if responding to increases in business risk 
is costly and undesirable to shareholders.  
 
Appendix A. Variable definitions 
<Insert Appendix Table A.1 here.>  
 
Appendix B. A mean-preserving increase in risk 
In the theoretical framework described in Section 2.2, similar changes in the pre-existing 
portfolio’s vega and the manager’s differential sensitivities to deviations in risk result if we model the 
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 increase in risk as a mean-preserving increase in stock price volatility rather than as an increase in left-tail 
risk. The portfolio vega after a mean-preserving increase in risk is plotted in Fig. B.1 for both portfolios, 
and the manager’s marginal utility with respect to stock return volatility is plotted in Fig. B.2. The decline 
in the options portfolio’s vega is smaller in the mean-preserving case than in the case of left-tail risk, but 
the decline is still greater than for the stock portfolio, which does not change (Fig. B.1). Nevertheless, 
similar to left-tail risk, an unexpected mean-preserving increase in stock price volatility has a smaller 
impact on a manager’s expected utility when the manager holds options rather than stock (Fig. B.2).  
The similarity is intuitive. A mean-preserving increase in volatility shifts stock volatility to the 
right along the expected utility curve (plotted in Figure 1), whereas the increase in left-tail risk, by 
reducing the expected cash flows, also shifts the manager’s expected utility curve to the left. In this 
regard, the expected marginal utilities after each increase in risk reflect similar mappings of the utility 
curve’s slope around the manager’s optimal volatility. The difference in marginal utilities also suggests 
that, when a firm sets a new compensation contract, the aggressiveness with which the manager will 
implement the implied level of risk-taking depends on the structure of the compensation contract. 
 
Appendix C. Decomposing changes in portfolio vega  
In Section 4.2, we report estimates that decompose the changes in exposed CEOs’ portfolio vega 
into three sources: changes in the vega of the pre-existing portfolio, additional vega from new option 
grants, and reduced vega from managers’ exercising options. Only the Execucomp sample provides 
sufficient information on both existing and newly granted options to compute these estimates. The 
estimates are based on the following methodology, which is an extension of Core and Guay (2002).   
To calculate the vega of CEOs’ pre-existing portfolio of options (vegapre) in the years after left-
tail risk increases, we apply the Core-Guay method to calculate the vega of CEOs’ existing options as of 
year T–1 in subsequent years by holding constant the number of options and their exercise prices but 
adjusting for changes in their maturity, the risk-free rate, and the firm’s dividend yield, stock price, and 
stock volatility. To calculate the vega of CEOs’ option grants after the increase in risk (vegaflow), we 
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 construct the portfolio that consists of options granted after the increase in tail risk and apply the Core-
Guay method to calculate the vega of this portfolio. Lastly, to calculate the vega of options exercised 
(vegaexercised), we construct the portfolio of exercised options and again apply the Core-Guay method to 
calculate the vega of this portfolio.  Because Execucomp only provides the number and value of exercised 
options but not their maturity or exercise price, we approximate these inputs by assuming that exercised 
options have the same average exercise price and maturity as the CEOs’ exercisable options in the 
previous year. 
Using the three above calculations, we can reconstruct the CEOs’ overall vega in the years after 
the increase in tail-risk. Specifically, the “implied” portfolio vega equals vegapre + vegaflow – vegaexercised. 
Despite the approximations required for these calculations, the implied vegas closely track observed 
vegas; for the average exposed CEO in our sample, the implied vega differs from the observed vega by 
only about 5%. 
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Fig. 1. Expected utility as a function of stock variance. This figure plots the expected utility of a 
manager as a function of the manager’s portfolio and the variance of the firm’s annual stock returns. 
The firm’s stock return is assumed to follow a lognormal process with an initial price of $50 and 
annual expected return of 10 percent, and the manager is assumed to have a power utility function 
with a coefficient of relative risk aversion of two. The options portfolio contains 50,000 options. The 
options are assumed to expire in ten years and have a 20 percent probability of being in the money at 
expiration. The stock portfolio contains 2,500 shares of stock. In both cases, the portfolio accounts for 
one-third of the manager’s total wealth. A positive affine transformation is used to rescale the level of 
expected utility. 
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Fig. 2. Portfolio vega after an increase in left-tail risk. This figure plots each portfolio’s vega after an 
increase in the probability of a left-tail risk, defined as an increase in the probability of a stock price 
realization below $10 at the time the options expire. The portfolio vega is calculated assuming a zero 
dividend yield, a risk free rate of five percent, and that the firm was at the manager’s optimal level of 
stock volatility prior to left-tail risk increasing. 
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Fig. 3. Marginal expected utility of risk after an increase in left-tail risk. This figure plots the manager’s 
marginal utility of risk after an increase in the probability of a left-tail risk, defined as an increase in the 
probability of a stock price realization below $10 at the time the options expire. This is the numerical 
derivative of the manager’s expected utility (shown in Figure 1) with respect to volatility, evaluated at the 
manager’s previously optimal level of stock volatility.  
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Fig. 4. Stock variance of exposed and unexposed firms. This figure plots the relative average 
annualized daily stock variance for exposed and unexposed firms, indexed to one in the year prior to a 
chemical being added to the Report on Carcinogens. 
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Fig. 5. Effect of exposure on flow vega, flow delta, and the value of options exercised by year. This 
figure reports the point estimates from firm-panel regressions of flow vega, flow delta, and the value 
of options exercised on an indicator for exposure, firm-by-cohort fixed effects, and year-by-cohort 
fixed effects. The specifications are the same as those reported in Table 2, columns 1, 4, and 7, except 
that the effect of exposure is allowed to vary by year in event time. 
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Fig. 6. Deconstructing exposed managers’ portfolio vega in year T+2. Panel A reports managers’ 
average portfolio vega in exposed and unexposed firms in the Execucomp sample by year relative to 
the increase in tail risk.  Panel B deconstructs the overall, average portfolio vega of exposed managers 
in year T+2 into its three components: vega from managers’ pre-exposure portfolio, new flows, and 
the drop in vega from exercising of options. Panel C plots the percent contribution of each source to 
the total drop in year T+2 relative to the counterfactual that exposed managers continue exercising 
the same number of options as they did in year T-1 and experience the same growth rate in their pre-
exposure portfolio vega and flow vega as unexposed managers during the same time period. 
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 Table 1 
Ex-ante firm characteristics. 
     This table reports summary statistics for firm characteristics in the three years before a new 
chemical was added to the Report on Carcinogens. The mean and standard deviation (in parentheses) 
for each variable are reported separately for two samples of firms. Column 1 reports estimates for 
firms in 4-digit SIC industries for which more than 5% of employees were observed to be exposed to 
the chemical in the 1981–1983 National Occupational Exposure Survey. Column 2 reports estimates 
for other firms in the same Fama-French 48-industry classification. Column 3 reports the p-value 
from a t-test of the difference between exposed and unexposed firms, where the standard errors are 
adjusted for clustering at the 4-digit SIC industry level. The sample is restricted to firms with non-
missing observations for portfolio vega and delta in the year prior to the new chemical being added to 
the Report on Carcinogens. 
 
Exposed Unexposed
p ‐value of 
difference
(1) (2) (3)
Firm characteristics
        Stock variance 0.243 0.177 0.350
(0.211) (0.189)
        Ln(assets) 7.151 7.438 0.472
(1.522) (1.396)
        Market‐to‐book ratio 0.026 0.026 0.992
(0.165) (0.063)
        Cash flows / assets 0.155 0.147 0.419
(0.088) (0.092)
Compensation characteristics
        Portfolio delta 326.2 519.3 0.299
(716.0) (2,537)
        Portfolio vega 41.74 27.60 0.591
(139.5) (112.2)
        Ln(total pay) 6.972 6.920 0.761
(0.955) (1.011)
        Options / total pay 0.313 0.265 0.562
(0.311) (0.254)
Observations 143 341
# of industries 43 82  
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 Table 2 
The effect of exposure on flow vega, flow delta, and options exercised. 
     This table reports coefficients from firm-panel regressions of flow vega, flow delta, and the value of options exercised on an indicator for 
exposure, firm-by-cohort fixed effects, and year-by-cohort fixed effects. Exposure equals one if more than 5% of employees in the firm’s 4-
digit SIC industry were observed to be exposed to a chemical listed in the most recent edition of the Report on Carcinogens (RoC), as reported 
in the 1981–1983 National Occupational Exposure Survey. The sample includes firm-year observations in the three years before and three 
years after each new chemical listing in the RoC for firms with non-missing portfolio vega and delta in the year prior to the new RoC listing. 
Columns 3, 6, and 9 exclude observations after a new chemical listing for which the CEO is different than the CEO in the year prior to the 
chemical being listed. Columns 2–3, 5–6, and 8–9 include firms’ Ln(assets) and CEOs’ tenure and salary + bonus as additional controls. 
Standard errors, adjusted for clustering at the industry level, are reported in parentheses. ***significant at the 1% level; **significant at the 5% 
level; *significant at 10% level. 
Dep. variable =
(1) (2) (3) (4) (5) (6) (7) (8) (9)
Exposure ‐7.60** ‐10.00*** ‐8.90** ‐12.88*** ‐24.61* ‐25.21* 790.8 1,063*** 1,184***
(3.11) (3.76) (3.89) (4.70) (13.67) (14.40) (575.9) (397.9) (429.2)
Observations 2,378 1,367 1,211 2,363 1,367 1,211 2,505 1,439 1,277
R 2 0.02 0.05 0.05 0.01 0.04 0.05 0.02 0.09 0.10
# of firms 469 309 264 469 309 264 484 320 275
Additional controls X X X X X X
Excludes new CEOs after T – 1 X X X
Fixed effects:
   Firm‐cohort X X X X X X X X X
   Year‐cohort X X X X X X X X X
Flow vega                    
Mean = 17.52                 
St. Dev. = 55.90
Flow delta                    
Mean = 20.37                 
St. Dev. = 83.06
Value of options exercised     
Mean = 912.9                 
St. Dev. = 4,546
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 Table 3 
Long-term effect of exposure on portfolio vega and portfolio delta. 
     This table reports coefficients from CEO-level regressions of post-exposure changes in portfolio vega and portfolio delta on an indicator for 
exposure and cohort fixed effects. Exposure is defined as in Table 2. The sample includes CEOs with non-missing portfolio vega and portfolio 
delta in the year prior to the RoC listing and excludes CEOs that are no longer present in the year in which the post-exposure change in 
incentives is calculated. The dependent variables are the three-, four-, five-, and six-year changes in portfolio vega and portfolio delta relative 
to the year prior to a chemical being added to the RoC. Standard errors, adjusted for clustering at the industry level, are reported in 
parentheses. **significant at the 5% level; *significant at 10% level.  
 
Dep. variable = Portfolio   
vega
Portfolio   
delta
Portfolio   
vega
Portfolio   
delta
Portfolio   
vega
Portfolio   
delta
Portfolio   
vega
Portfolio   
delta
(1) (2) (3) (4) (5) (6) (7) (8)
Exposure ‐24.60 ‐181.7 ‐43.71 ‐346.4** ‐43.66 ‐448.2* ‐55.31* ‐483.8**
(26.06) (132.0) (27.49) (151.8) (28.35) (229.2) (28.95) (225.1)
Observations 334 334 262 262 251 251 218 218
R 2 0.02 0.05 0.02 0.05 0.05 0.02 0.06 0.02
Excludes new CEOs after T – 1 X X X X X X X X
Cohort fixed effects X X X X X X X X
5‐year Δ in incentives  
[T+4] versus [T‐1]
4‐year Δ in incentives  
[T+3] versus [T‐1]
3‐year Δ in incentives  
[T+2] versus [T‐1]
6‐year Δ in incentives  
[T+5] versus [T‐1]
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 Table 4 
The effect of exposure on newly hired CEOs’ portfolio vega. 
     This table reports coefficients from CEO-level regressions of the level of and change in portfolio vega on an indicator for exposure, year-by-
cohort fixed effects, and an indicator for operating in an industry-cohort with an exposure. Exposure is defined as in Table 2. The sample includes 
observations from a CEO’s first year in office for CEOs hired in the three years before and three years after each new chemical listing in the RoC. 
To ensure the same sample of firms as in earlier specifications, we continue to restrict the sample to firms with non-missing portfolio vega and 
portfolio delta in the year prior to the new RoC listing.  The dependent variable in columns 1–2 is the initial portfolio vega of the newly hired 
CEO, and the dependent variable in columns 3–4 is the difference between the new CEO’s initial portfolio vega and the portfolio vega of the 
outgoing CEO. Column 2 includes firms’ Ln(assets) and the new CEOs’ tenure and salary + bonus as additional controls, and column 4 includes 
the changes in these variables as controls. Standard errors, adjusted for clustering at the industry level, are reported in parentheses. *significant at 
10% level. 
 
Dep. variable =
(1) (2) (3) (4)
Exposure ‐49.4* ‐30.3* ‐111.5 ‐84.6*
(25.8) (17.7) (67.2) (42.3)
Observations 175 149 167 71
R 2 0.09 0.45 0.08 0.36
Exposed industry‐cohort indicator X X X X
Year‐cohort fixed effects X X X X
Additional controls X X
Portfolio vega of 
newly‐hired CEO
Δ portfolio vega      
from prior CEO
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 Table 5 
The effects of exposure and payoff structure on firms’ stock variance. 
     This table reports coefficients from firm-panel regressions of annualized daily stock variance on 
Exposure (an indicator for exposure) and its interactions with portfolio vega and portfolio delta in the year 
prior to an increase in tail risk, firm-by-cohort fixed effects, and year-by-cohort fixed effects. Exposure is 
defined as in Table 2. The sample includes firms with non-missing portfolio vega and portfolio delta in 
the year prior to the RoC listing and excludes firm-year observations after a new chemical listing for 
which the CEO is different than the CEO in the year prior to the chemical being listed. For ease of 
interpreting the exposure coefficient and its interactions, the portfolio vega and portfolio delta are 
demeaned and rescaled by their sample standard deviation [i.e., φ(X) = (X - μX)/σX] before being 
interacted with Exposure. Column 3 includes firms’ Ln(sales), debt/assets, R&D/sales (with missing 
values replaced with zeros), and market-to-book ratio as additional controls. Standard errors, adjusted for 
clustering at the industry level, are reported in parentheses. **significant at the 5% level; *significant at 
10% level. 
 
Dep. variable =
(1) (2) (3)
Exposure 0.102 0.094 0.097*
(0.068) (0.059) (0.056)
Exposure × φ(Vega T – 1) 0.049** 0.047**
(0.019) (0.019)
Exposure × φ(Delta T – 1) 0.023 0.039
(0.053) (0.050)
Observations 2,620 2,620 2,562
R 2 0.22 0.23 0.24
# of firms 484 484 480
Excludes new CEOs after T – 1 X X X
Additional controls X
Fixed effects:
   Firm‐cohort X X X
   Year‐cohort X X X
Stock variance                    
Mean = 0.23                       
St. Dev. = 0.29
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 Table 6 
The effects of exposure and payoff structure on firms’ financial risk. 
     This table reports coefficients from firm-panel regressions of debt/assets and cash/assets on Exposure 
(an indicator for exposure) and its interactions with portfolio vega and portfolio delta in the year prior to 
an increase in tail risk, firm-by-cohort fixed effects, and year-by-cohort fixed effects. The specification is 
the same as in Table 5. For ease of interpreting the exposure coefficient and its interactions, the portfolio 
vega and portfolio delta are demeaned and rescaled by their sample standard deviation [i.e., φ(X) = (X - 
μX)/σX] before being interacted with Exposure. The additional controls follow Hayes et al. (2012); in 
column 3, they include firms’ Ln(sales), EBITDA/assets, R&D/sales (with missing values replaced with 
zeros), and PP&E/assets; and in column 6, they include firms’ Ln(sales), debt/assets, R&D/sales (with 
missing values replaced with zeros), and market-to-book ratio. Standard errors, adjusted for clustering at 
the industry level, are reported in parentheses. ***significant at the 1% level; **significant at the 5% 
level; *significant at 10% level. 
Dep. variable =
(1) (2) (3) (4) (5) (6)
Exposure ‐0.005 ‐0.006 ‐0.014 0.003 0.004 0.005
(0.012) (0.013) (0.011) (0.007) (0.007) (0.007)
Exposure × φ(Vega  T – 1 ) 0.009* 0.005 ‐0.006*** ‐0.006***
(0.005) (0.004) (0.002) (0.002)
Exposure × φ(Delta T – 1 ) ‐0.056** ‐0.066*** 0.021*** 0.019**
(0.023) (0.018) (0.006) (0.008)
Observations 2,597 2,597 2,588 2,230 2,230 2,210
R 2 0.03 0.04 0.11 0.04 0.04 0.07
# of firms 481 481 481 454 454 452
Excludes new CEOs after T – 1 X X X X X X
Additional controls X X
Fixed effects:
   Firm‐cohort X X X X X X
   Year‐cohort X X X X X X
Debt/assets                  
Mean = 0.25                 
St. Dev. = 0.17
Cash/assets                   
Mean = 0.067                 
St. Dev. = 0.094
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 Table 7 
The effects of exposure and payoff structure on investment risk. 
     This table reports coefficients from firm-panel regressions of R&D/assets and an indicator for 
undertaking a diversifying acquisition on Exposure (an indicator for exposure) and its interactions with 
portfolio vega and portfolio delta in the year prior to an increase in tail risk, firm-by-cohort fixed effects, 
and year-by-cohort fixed effects. The specification is the same as in Table 5. For ease of interpreting the 
exposure coefficient and its interactions, the portfolio vega and portfolio delta are demeaned and rescaled 
by their sample standard deviation [i.e., φ(X) = (X - μX)/σX] before being interacted with Exposure. The 
additional controls follow Hayes et al. (2012); in column 3, they include firms’ Ln(sales), sales growth, 
debt/assets, stock return, surplus cash/assets, and market-to-book ratio and CEOs’ salary + bonus; and in 
column 6, they include firms’ Ln(sales), EBITDA/assets, debt/assets, stock return, and market-to-book 
ratio, CEOs’ tenure and salary + bonus, and a CEO exit indicator. Standard errors, adjusted for clustering 
at the industry level, are reported in parentheses. ***significant at the 1% level; **significant at the 5% 
level. 
Dep. variable =
(1) (2) (3) (4) (5) (6)
Exposure ‐0.003 ‐0.004 ‐0.0003 0.024 0.029 0.030
(0.002) (0.002) (0.002) (0.034) (0.036) (0.037)
Exposure × φ(Vega T – 1) 0.002*** 0.001*** ‐0.026*** ‐0.022***
(0.0002) (0.0003) (0.006) (0.008)
Exposure × φ(Delta T – 1) ‐0.002 0.006* 0.055** 0.034
(0.002) (0.005) (0.026) (0.035)
Observations 1,361 1,361 1,352 2,645 2,645 2,576
R 2 0.06 0.06 0.18 0.02 0.02 0.02
# of firms 259 259 259 484 484 480
Excludes new CEOs after T – 1 X X X X X X
Additional controls X X
Fixed effects:
   Firm‐cohort X X X X X X
   Year‐cohort X X X X X X
Diversifying acq. indicator     
Mean = 0.13                  
St. Dev. = 0.34
R&D/assets                  
Mean = 0.049                 
St. Dev. = 0.048
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 Table 8 
Controlling for possible omitted variables. 
     This table reports coefficients from firm-panel regressions of annualized daily stock variance, 
cash/assets, debt/assets, R&D/assets, and an indicator for undertaking a diversifying acquisition on 
Exposure (an indicator for exposure) and its interactions with portfolio vega and portfolio delta in the year 
prior to an increase in tail risk, firm-by-cohort fixed effects, and year-by-cohort fixed effects. The 
specifications are the same as those reported in Tables 5–7, but also include as controls additional 
interactions between Exposure and various CEO and firm characteristics in the year prior to a new RoC 
listing. The following characteristics are each interacted separately with Exposure: Ln(assets), a dividend 
indicator, debt/assets (except for column 3), modified Altman z-score, cash flows/assets, institutional 
ownership, CEO tenure, and CEO age. Standard errors, adjusted for clustering at the industry level, are 
reported in parentheses. ***significant at the 1% level; **significant at the 5% level; *significant at the 
10% level. 
 
Dep. variable =
(1) (2) (3) (4) (5)
Exposure 0.147*** 0.0221** ‐0.003 0.005 0.057
(0.040) (0.011) (0.019) (0.003) (0.052)
Exposure × φ(Vega T – 1) 0.026* ‐0.006*** 0.007* 0.002*** ‐0.033***
(0.015) (0.002) (0.004) (0.000) (0.008)
Exposure × φ(Delta T – 1) 0.039 0.0213** ‐0.075*** 0.001 0.056
(0.043) (0.009) (0.021) (0.002) (0.044)
Observations 1,393 1,287 1,403 772 1,403
R 2 0.35 0.06 0.07 0.10 0.06
# of firms 253 246 253 144 253
Excludes new CEOs after T – 1 X X X X X
Additional Exposure interactions X X X X X
Fixed effects:
   Firm‐cohort X X X X X
   Year‐cohort X X X X X
Stock 
variance
Cash/      
assets
Debt/      
assets
R&D/      
assets
Diversifying 
acquisition
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 Table A.1       
Variable Definitions     
         
       
Dependent variables   
 Portfolio delta   Manager’s change in wealth (expressed in thousands of dollars) for a 1% increase in the firm’s stock price. Calculated 
from managers’ complete portfolio of stock and options from Execucomp or Yermack  (1995) using the methodology 
from Core  and Guay  (2002). The  value of  the option portfolio  is  the  sum of  the Black‐Scholes  values of  the newly 
granted  options  and  previously  granted  unexercisable  and  exercisable  options.  The  Yermack  sample  contains 
information on a manager’s previously granted stock but not options, so we use information only on options granted in 
the last year to calculate the managers’ options’ delta. 
 Portfolio vega   Manager’s  change  in  wealth  (expressed  in  thousands  of  dollars)  for  a  0.01  increase  in  the  annualized  standard 
deviation of firm’s stock returns.  Calculated from managers’ complete portfolio of stock and options from Execucomp 
or Yermack  (1995) using the methodology  from Core and Guay  (2002). See the definition of Portfolio delta for more 
detail. 
 Flow delta   Same as Portfolio delta but calculated using only stocks and options granted in given year. In the Execucomp  sample, 
the number of  shares granted  is approximated using  rstkgrnt/prccf, and  in  the Yermack  sample,  it  is approximated 
using othcomp/endprice. 
 Flow vega   Same as Portfolio vega but calculated using only options granted in given year. 
 Value exercised   Calculated as opt_exer_val in the Execucomp sample and as optgains in the Yermack sample. 
 Cash/assets   Calculated from Compustat using ch/at. 
 Debt/assets   Calculated from Compustat using (dltt + dlc)/at. 
 Diversifying  
  acquisition indicator 
Calculated  using  SDC's  Mergers  and  Acquisitions  Database.  The  indicator  equals  one  if  the  firm  undertakes  an 
acquisition where its primary SIC industry does not coincide with any SIC code of the target firm. 
 R&D/assets   Calculated from Compustat using xrd/at. 
 Stock variance   Calculated from CRSP using the sum of squared daily returns over the year. To adjust for differences in the number of 
trading days, the raw sum is multiplied by 252 and divided by the number of trading days.  
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Firm‐level controls (from Compustat) 
 Cash flows/assets  (oiadp – accruals) / at, where accruals = (actt – actt‐1) – (chet – chet‐1) – (lctt – lctt‐1) + (dlct – dlct‐1) – dp 
 EBITDA/assets   oibdp/at 
 Ln(assets)   ln(at) 
 Ln(sales)     ln(sale) 
 Market‐to‐book ratio  (csho * prcc_c)/ceq 
 PP&E/assets   ppent/at 
 R&D/sales   min(0, xrd/sale) 
 Sales growth   ln(salet) ‐ ln(salet‐1) 
 Surplus cash/assets   (oancf – dpc + xrd) / at 
       
Firm‐level controls (from CRSP) 
 Stock return   Calendar‐year total stock return, compounded from monthly holding period returns where ordinary dividends are 
reinvested at month‐end. 
       
CEO‐level controls   
 CEO age     Age of CEO obtained from Disclosure database between 1990 and 2004, provided by James S. Linck. 
 CEO tenure   Number of  years  a manager has been CEO, which  is obtained  from Disclosure database between 1990  and 2004, 
provided by James S. Linck. Missing values are imputed when possible. 
 CEO exit   Indicator that equals one in the year that a CEO turns over. 
 Ln(total pay)   Calculated as ln(tdc1) in the Execucomp sample and ln(salbon + othcomp + grantval) in the Yermack sample. 
 Options/total pay   Calculated as option_awards_blk_value/tdc1  in the Execucomp sample and grantval / (salbon + othcomp + grantval) 
in the Yermack sample. 
 Salary + bonus   Calculated as salary + bonus in the Execucomp sample and salbon in the Yermack sample. 
       
Note: All variables that represent a dollar value, including delta and vega, are adjusted for inflation using the annual average CPI index for 
urban consumers from the Bureau of Labor Statistics. 
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Fig. B.1. Portfolio vega after a mean-preserving increase in risk. This figure plots each portfolio’s vega 
after a mean-preserving increase in stock variance. The portfolio vega is calculated assuming a zero 
dividend yield, a risk-free rate of five percent, and that the firm was at the manager’s optimal level of 
stock volatility prior to risk increasing. 
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Fig. B.2. Marginal expected utility of risk after a mean-preserving increase in risk. This figure plots the 
manager’s marginal utility of risk after a mean-preserving increase in stock variance. This is the 
numerical derivative of the manager’s expected utility (shown in Figure 1) with respect to variance at 
points above the manager’s previously optimal level of stock variance. 
55
